Persistent NKH with transient or absent symptoms and a homozygous GLDC mutation.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 15236413.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Three of four nonketotic hyperglycinemia patients homozygous for a novel GLDC mutation (A802V) were treated by assisted respiration and/or sodium benzoate with or without ketamine and had transient neonatal or absent symptoms and normal developmental outcome, despite persisting biochemical evidence of nonketotic hyperglycinemia. This exceptional outcome may be related to the high residual activity of the mutant protein (32% of wild type) and therapeutic intervention during a critical period of heightened brain exposure and sensitivity to glycine.
Medical subject headings
- Amino Acid Oxidoreductases
- Hyperglycinemia, Nonketotic
- Point Mutation